GT Biopharma Inc. Common Stock

GTBP us
$6.89
▲ +0.06 (+0.88%)
Volume: 79,742 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 33
  • 21d momentum -5.0%
  • MA aligned bearish
  • RSI 46
🎯 Pullback 50
  • -5.4% vs 20MA
💎 Value 58
  • -80% off 52w high

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)46.1
MACD-0.049
MA trendBearish
ATR14.92%
21d mom.-5.0%
63d mom.-35.9%
vs 20MA-5.4%
RVOL(20)0.66×
52w low · 5 52w high · 34
-79.9% from 52-week high
20d support 5 · resistance 12

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap$12M
PER—
PBR3.45
PSR—
EPS$-18.16
ROE-917.9%
ROA-566.0%
Dividend yield1.86%
Debt/Equity0.00
EV/EBITDA-0.45
week1M3M6M1YYTD
-3.77% -5.00% -35.91% -38.21% -65.55% -66.27%

Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
9/10
🐻 Bear
7/10

14d momentum +14.36%, daily vol 12.00%. GT Biopharma Inc. Common Stock sits in a bullish regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.